Skip to Main Content

Rise and shine, everyone, another busy day is clearly on the way. The world seems to be spinning faster suddenly, does it not? Well, in such moments, there is only one thing to do — brew a cup of stimulation. Not that we need any help staying awake right now, but why not get an extra edge, yes? On that note, time to dig in to the to-do list and get cracking. As for you, here are some tidbits to help on your own journey. Hope all goes well today and you stay healthy.

The Bill & Melinda Gates Foundation, along with the Wellcome research charity and Mastercard, are launching a $125 million effort to speed drug development to treat the novel coronavirus, STAT writes. The initiative, the Covid-19 Therapeutics Accelerator, will not be enough to develop a single new medicine by itself, but can jump-start the process. The plan is to provide funds to as many as two dozen companies and academic researchers immediately, before government funding will be available.


In its rush to begin clinical trials on a potential coronavirus treatment, Gilead Sciences (GILD) may have violated federal law instead of waiting for slow-to-come federal approvals on drug exports, Axios reports. The company shipped a batch of its investigational drug, called remdesivir, to China after requesting — but not receiving — federal approval from the Department of Health and Human Services, which is required by law. And the move caused consternation within the senior ranks of the Trump administration.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!